These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 18534600)
41. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032 [TBL] [Abstract][Full Text] [Related]
42. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens. Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174 [TBL] [Abstract][Full Text] [Related]
43. Overlapping antigenic repertoires of variant antigens expressed on the surface of erythrocytes infected by Plasmodium falciparum. Giha HA; Staalsoe T; Dodoo D; Elhassan IM; Roper C; Satti GM; Arnot DE; Hviid L; Theander TG Parasitology; 1999 Jul; 119 ( Pt 1)():7-17. PubMed ID: 10446700 [TBL] [Abstract][Full Text] [Related]
44. Distinct patterns of blood-stage parasite antigens detected by plasma IgG subclasses from individuals with different level of exposure to Plasmodium falciparum infections. Olesen CH; Brahimi K; Vandahl B; Lousada-Dietrich S; Jogdand PS; Vestergaard LS; Dodoo D; Højrup P; Christiansen M; Larsen SO; Singh S; Theisen M Malar J; 2010 Oct; 9():296. PubMed ID: 20977761 [TBL] [Abstract][Full Text] [Related]
45. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas. Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641 [TBL] [Abstract][Full Text] [Related]
46. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Taylor RR; Allen SJ; Greenwood BM; Riley EM Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783 [TBL] [Abstract][Full Text] [Related]
47. Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Rovira-Vallbona E; Moncunill G; Bassat Q; Aguilar R; Machevo S; Puyol L; Quintó L; Menéndez C; Chitnis CE; Alonso PL; Dobaño C; Mayor A Malar J; 2012 May; 11():181. PubMed ID: 22646809 [TBL] [Abstract][Full Text] [Related]
48. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789 [TBL] [Abstract][Full Text] [Related]
49. Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies. Jakobsen PH; Heegaard PM; Koch C; Wasniowska K; Lemnge MM; Jensen JB; Sim BK Infect Immun; 1998 Sep; 66(9):4203-7. PubMed ID: 9712768 [TBL] [Abstract][Full Text] [Related]
50. [Specific antibodies to Plasmodium falciparum antigens in immune patients: IV--Cross-sectional analysis of anti-P. falciparum Ab responses in a mesoendemic zone of transmission in Sine-Saloum region]. Sidibé S; Diouf B; Tall A; Spiegel A; Trape JF; Garraud O; Dièye A; Perraut P Dakar Med; 2000; 45(2):117-21. PubMed ID: 15779164 [TBL] [Abstract][Full Text] [Related]
51. Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Abdel-Latif MS; Khattab A; Lindenthal C; Kremsner PG; Klinkert MQ Infect Immun; 2002 Dec; 70(12):7013-21. PubMed ID: 12438381 [TBL] [Abstract][Full Text] [Related]
52. Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania. Vestergaard LS; Lusingu JP; Nielsen MA; Mmbando BP; Dodoo D; Akanmori BD; Alifrangis M; Bygbjerg IC; Lemnge MM; Staalsoe T; Hviid L; Theander TG Infect Immun; 2008 Jun; 76(6):2706-14. PubMed ID: 18250179 [TBL] [Abstract][Full Text] [Related]
53. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. Persson KE; McCallum FJ; Reiling L; Lister NA; Stubbs J; Cowman AF; Marsh K; Beeson JG J Clin Invest; 2008 Jan; 118(1):342-51. PubMed ID: 18064303 [TBL] [Abstract][Full Text] [Related]
54. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Metzger WG; Okenu DM; Cavanagh DR; Robinson JV; Bojang KA; Weiss HA; McBride JS; Greenwood BM; Conway DJ Parasite Immunol; 2003 Jun; 25(6):307-12. PubMed ID: 14507328 [TBL] [Abstract][Full Text] [Related]
55. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique. Nhabomba AJ; Guinovart C; Jiménez A; Manaca MN; Quintó L; Cisteró P; Aguilar R; Barbosa A; Rodríguez MH; Bassat Q; Aponte JJ; Mayor A; Chitnis CE; Alonso PL; Dobaño C Malar J; 2014 Mar; 13():121. PubMed ID: 24674654 [TBL] [Abstract][Full Text] [Related]
56. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896 [TBL] [Abstract][Full Text] [Related]
57. Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. Ondigo BN; Hodges JS; Ireland KF; Magak NG; Lanar DE; Dutta S; Narum DL; Park GS; Ofulla AV; John CC J Infect Dis; 2014 Oct; 210(7):1123-32. PubMed ID: 24737801 [TBL] [Abstract][Full Text] [Related]
58. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission. Torres KJ; Clark EH; Hernandez JN; Soto-Cornejo KE; Gamboa D; Branch OH Malar J; 2008 Sep; 7():173. PubMed ID: 18782451 [TBL] [Abstract][Full Text] [Related]
59. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort. Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998 [TBL] [Abstract][Full Text] [Related]